ArticleBeilstein journal of nanotechnology2019

Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells.

Hannah Onafuye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.